Treatment of hypoalbuminemia is largely focused on the underlying cause and not on the hypoalbuminemia itself. Albumin infusions can and are commonly performed although they are expensive and have not been shown to be more effective than colloid solutions in a number of conditions and situations. Examples of indications for albumin infusion include hypoalbuminemia in the context of major surgery such as hepatic resection >40%, nephrotic<unk>  in conjunction with diuretics and corticosteroids, spontaneous bacterial peritonitis in combination with antibiotics, and rapidly progressing hepatorenal<unk>  (type 1) in combination with terlipressin. It is also used to prevent iatrogenic hypoalbuminemia after therapeutic plasmapheresis if volume plasma exchange is greater than 20 milliliters per kilogram in one session or over one week across multiple sessions and after large volume (>5 liter) paracentesis in ascites. These indications have shown positive outcomes respective to their diseases, while conditions like malnourishment, burns (during the first 24 hours), and shock with traumatic brain injury either show no benefit or harm in randomized controlled trials. In liver disease and cirrhosis, in addition to the above indications, the use of albumin is being considered for bacterial infections other than spontaneous bacterial peritonitis, hepatic encephalopathy, and chronic ascites. Its use in these indications remains controversial. In kidney disease and nephrotic<unk> , albumin infusions as replacement for albumin loss to proteinuria is used in some cases of congenital nephrotic<unk> .
symptoms of Capillary leak syndrome
symptom of Capillary leak syndrome
symptoms of Fat embolism syndrome
symptom of Fat embolism syndrome
symptom of Pulmonary embolism
symptoms of Air embolism
symptoms of Pulmonary embolism
symptom of Air embolism